BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34923232)

  • 1. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
    Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
    Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold.
    Gudmundsdottir Á; Scheving R; Lindberg F; Stefansson B
    J Med Virol; 2021 Mar; 93(3):1792-1795. PubMed ID: 32975843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach.
    Dehghan Z; Mirmotalebisohi SA; Mozafar M; Sameni M; Saberi F; Derakhshanfar A; Moaedi J; Zohrevand H; Zali H
    Daru; 2024 Jun; 32(1):215-235. PubMed ID: 38652363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shufeng Jiedu, a promising herbal therapy for moderate COVID-19:Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study.
    Xia L; Shi Y; Su J; Friedemann T; Tao Z; Lu Y; Ling Y; Lv Y; Zhao R; Geng Z; Cui X; Lu H; Schröder S
    Phytomedicine; 2021 May; 85():153390. PubMed ID: 33158717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.
    Pasquereau S; Nehme Z; Haidar Ahmad S; Daouad F; Van Assche J; Wallet C; Schwartz C; Rohr O; Morot-Bizot S; Herbein G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
    Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
    PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs Against Human Coronavirus 229E (HCoV-229E).
    Parang K; El-Sayed NS; Kazeminy AJ; Tiwari RK
    Molecules; 2020 May; 25(10):. PubMed ID: 32429580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust Evaluation of Ultraviolet-C Sensitivity for SARS-CoV-2 and Surrogate Coronaviruses.
    Boegel SJ; Gabriel M; Sasges M; Petri B; D'Agostino MR; Zhang A; Ang JC; Miller MS; Meunier SM; Aucoin MG
    Microbiol Spectr; 2021 Oct; 9(2):e0053721. PubMed ID: 34668746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
    Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
    Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
    J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral strategies against human coronaviruses.
    Pyrc K; Berkhout B; van der Hoek L
    Infect Disord Drug Targets; 2007 Mar; 7(1):59-66. PubMed ID: 17346212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
    Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
    Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the hologic panther fusion.
    Cordes AK; Rehrauer WM; Accola MA; Wölk B; Hilfrich B; Heim A
    J Med Virol; 2021 Jul; 93(7):4438-4445. PubMed ID: 33350484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.